This may be influenced by the genetic or epigenetic profile of these distinct breast cancer subsets, such as the presence of PIK3CA mutations and increased INPP4B, or the expression of effectors that mediate PI3K suppression of Wnt signaling. This evidence concerns the gene PIK3CD and breast carcinoma.